跳至主要内容
临床试验/NCT02806388
NCT02806388招募中不适用

Individualized Molecular Profiling for Allocation to Clinical Trials (IMPACT) Project

National Cancer Centre, Singapore1 个研究点 分布在 1 个国家目标入组 5,500 人开始时间: 2011年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
5,500
试验地点
1
主要终点
The molecular and clinical epidemiology for cancer patients being considered for novel therapeutics

研究概览

简要总结

This study aims to screen tumor molecular profile for better selection of anticancer treatment, in particular, allocation to clinical trials if available.

详细描述

Molecular profiling will be performed on archival tumor tissue or freshly collected tumor tissue from re-biopsy. Blood, pleural fluid, FNA, and/or saliva may be collected to study the genetic makeup and also to compare the tumor molecular profile. Personalized therapy will be given based on molecular profile.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Confirmed histological diagnosis of solid tumor
  • Suitable for systematic treatment and clinical trials
  • ECOG (Eastern cooperative oncology group) performance status < 2
  • Able to provide tumor tissue for molecular profiling
  • Able to understand and sign the informed consent form

排除标准

  • 未提供

结局指标

主要结局

The molecular and clinical epidemiology for cancer patients being considered for novel therapeutics

时间窗: 5 years

次要结局

  • The correlation of molecular profiles with clinical outcomes(5 years)
  • The proportion of patients who have actionable alterations and enrol into clinical trials(5 years)

研究者

发起方
National Cancer Centre, Singapore
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验